FAMILIAL AGGREGATION OF MALIGNANT LYMPHOMAS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Familial aggregation of malignant lymphomas is encountered rather commonly -only in 0.7-3.0% of cases. The incidence of non-Hodgkin lymphoma and Hodgkin lymphoma in one family (in parent-child and brother-sister pairs) is highest. In this case, the disease is generally characterized by the aggressive course and more frequent occurrence of the lymphomas in younger infants than in their parents. The paper describes cases of aggregation of familial lymphomas in the patients who have been treated at the N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation.

Full Text

Restricted Access

About the authors

D. Zvyagintseva

N.N. Petrov Research Institute of Oncology

T. Semiglazova

N.N. Petrov Research Institute of Oncology; I.I. Mechnikov North-Western State Medical University

L. Filatova

N.N. Petrov Research Institute of Oncology

D. Kurochkina

N.N. Petrov Research Institute of Oncology

A. Artemyeva

N.N. Petrov Research Institute of Oncology

S. Kuleva

N.N. Petrov Research Institute of Oncology; Saint Petersburg State Pediatric Medical University

References

  1. Беляев А.М., Мерабишвили В.М. Злокачественные новообразования в Северо-Западном федеральном округе. 2-й вып. / СПб, 2015.
  2. Имянитов Е.Н., Хансон К.П. Эпидемиология и биология неходжкинских лимфом // Практическая онкология. - 2004; 5 (3): 163.
  3. Бобынцева О.В., Болдинова Е.О., Иванов В.П. и др. Анализ уровня спонтанного мутагенезана разных стадиях злокачественных лимфом // Applied and fundamental research. - 2015; 1: 76-9.
  4. de Haan L., Loves S., Daenen S. Familial Aggregation of Non-Hodgkin’s Lymphoma (NHL) // A Case Report, Hereditary Cancer in Clinical Practice. - 2006; 4 (3): 136-9.
  5. Adler B., Barchana M., Ben Yehuda D. et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma // Cancer. - 2000; 88: 2357-66.
  6. Adami H., Chang E., Glimelius B. et al. Family History of Hematopoietic Malignancy and Risk of Lymphoma // J. National Cancer Institute. - 2005; 97 (19).
  7. Dancey J., Cheson B., Chiu B. et al. Update on epidemiology and therapeutics for non-Hodgkin’s lymphoma // Hematology (Am. Soc. Hematol. Educ. Program). - 2002; 241 (62).
  8. Harris N., Jaffe E., Stein H. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. WHO Classification of Tumours, Vol. 3 IARC WHO Classification of Tumours. - 2001; 3: 351.
  9. Kari V., Nambiar M., Raghavan S. Chromosomal translocations in cancer // Biochim. Biophys. Acta. - 2008; 2: 139-52.
  10. Gail M., Goldin L., Gridley G. et al. Familial Aggregation of Hodgkin Lymphoma and Related Tumors // Cancer. - 2004; 100 (9): 1902-8.
  11. Czene K., Hemminki K., Li X. Familial risk of cancer: data for clinical counseling and cancer genetics // Cancer. - 2004; 108: 109-14.
  12. Carrington M., Goldstein A., Harty L. et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease // Blood. - 2002; 99: 690-3.
  13. Hemminki K., Czene K. Attributable risks of familial cancer from the Family-Cancer Database // Cancer Epidemiol. Biomarkers Prev. - 2002; 11: 1638-44.
  14. Cfan W., Rosenvald A., Wright G. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma // N. Engl. J. Med. - 2002; 364: 1937-47.
  15. Armitage J., Alizadeh A., Chan W. et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile // Blood. - 2002; 99: 2285-90.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies